sch 34826 has been researched along with enkephalin, leucine-2-alanine in 1 studies
| Studies (sch 34826) | Trials (sch 34826) | Recent Studies (post-2010) (sch 34826) | Studies (enkephalin, leucine-2-alanine) | Trials (enkephalin, leucine-2-alanine) | Recent Studies (post-2010) (enkephalin, leucine-2-alanine) |
|---|---|---|---|---|---|
| 31 | 2 | 0 | 1,581 | 23 | 74 |
| Protein | Taxonomy | sch 34826 (IC50) | enkephalin, leucine-2-alanine (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.0915 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0017 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.009 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0419 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 1.4691 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.009 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borea, PA; Ongini, E; Trampus, M; Varani, K | 1 |
1 other study(ies) available for sch 34826 and enkephalin, leucine-2-alanine
| Article | Year |
|---|---|
The neutral endopeptidase-24.11 inhibitor SCH 34826 does not change opioid binding but reduces D1 dopamine receptors in rat brain.
Topics: Analgesics; Animals; Brain Chemistry; Dioxolanes; Dipeptides; Dopamine Antagonists; Enkephalin, Leucine-2-Alanine; Etorphine; Kinetics; Male; Morphine; Neprilysin; Rats; Rats, Inbred Strains; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu; Receptors, sigma | 1991 |